AU5717990A - Magnetic protein conjugates, a process for the preparation thereof and the use thereof - Google Patents

Magnetic protein conjugates, a process for the preparation thereof and the use thereof

Info

Publication number
AU5717990A
AU5717990A AU57179/90A AU5717990A AU5717990A AU 5717990 A AU5717990 A AU 5717990A AU 57179/90 A AU57179/90 A AU 57179/90A AU 5717990 A AU5717990 A AU 5717990A AU 5717990 A AU5717990 A AU 5717990A
Authority
AU
Australia
Prior art keywords
preparation
protein conjugates
magnetic protein
magnetic
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57179/90A
Inventor
Reiner Donges
Karlheinz Enssle
Udo Franssen
Peter Hermentin
Roland Kurrle
Friedrich-Robert Seiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU5717990A publication Critical patent/AU5717990A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles
AU57179/90A 1989-06-19 1990-06-18 Magnetic protein conjugates, a process for the preparation thereof and the use thereof Abandoned AU5717990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3919923 1989-06-19
DE3919923A DE3919923A1 (en) 1989-06-19 1989-06-19 MAGNETIC PROTEIN CONJUGATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Publications (1)

Publication Number Publication Date
AU5717990A true AU5717990A (en) 1990-12-20

Family

ID=6383013

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57179/90A Abandoned AU5717990A (en) 1989-06-19 1990-06-18 Magnetic protein conjugates, a process for the preparation thereof and the use thereof

Country Status (7)

Country Link
EP (1) EP0403960A2 (en)
JP (1) JPH0341098A (en)
AU (1) AU5717990A (en)
CA (1) CA2019217A1 (en)
DE (1) DE3919923A1 (en)
IE (1) IE902195A1 (en)
PT (1) PT94399A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4033714C3 (en) * 1990-10-24 1995-09-07 Brahms Diagnostica Gmbh New hapten analysis based on the principle of an antigen-antibody reaction
GB9105031D0 (en) * 1991-03-09 1991-04-24 Fisons Plc Processing analytical reagents
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
NO180658C (en) 1994-03-10 1997-05-21 Oeystein Fodstad Method and Device for Detecting Specific Target Cells in Specialized or Mixed Cell Populations and Solutions Containing Mixed Cell Populations
NO961031D0 (en) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Procedure for killing unwanted target cells
KR20030047499A (en) * 2001-12-11 2003-06-18 김근상 Multi-terminal plug and jack

Also Published As

Publication number Publication date
CA2019217A1 (en) 1990-12-19
PT94399A (en) 1991-02-08
IE902195A1 (en) 1991-01-02
EP0403960A2 (en) 1990-12-27
JPH0341098A (en) 1991-02-21
DE3919923A1 (en) 1990-12-20
IE902195L (en) 1990-12-19

Similar Documents

Publication Publication Date Title
AU4589289A (en) Synthetic antigens, a process for the preparation thereof and the use thereof
AU5267190A (en) Modified antibodies
AU5309590A (en) Electrofusion marker
AU634518B2 (en) Hepatitis B core antigen conjugates
AU624436B2 (en) Albumin preparation and process for preparing the same
AU4733389A (en) Bisindenyl derivatives, and a process for the preparation thereof
AU2653788A (en) Manumycin derivatives, a process for the preparation thereof, and the use thereof
AU4935390A (en) A novel substituted-acetamide compound and a process for the preparation thereof
AU6209790A (en) Pyridinyl-quinolone compounds, their preparation and use
AU4926190A (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use
AU5717990A (en) Magnetic protein conjugates, a process for the preparation thereof and the use thereof
AU5388090A (en) N-sulfenyl- and n-sulfinyl-n,n'-diacylhydrazides
AU633073B2 (en) Stabilized synthetic zeolite and a process for the preparation thereof
AU2878989A (en) Antibody conjugates
AU5828990A (en) Beeper amplifier
AU2975089A (en) Novel compounds, process for the preparation thereof and uses thereof
AU6255690A (en) Opaliform porcellanite and process for the preparation thereof
AU6118090A (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines, and process for their preparation
AU4944090A (en) Cryoelectrosynthesis
AU629720B2 (en) Sulfonated propylphenylphosphines, their preparation and use
AU5742490A (en) Shirt
AU6689590A (en) Pyridine-2,4- and 2,5-dicarboxamides, a process for the preparation thereof, and the use thereof
AU5830490A (en) Trolleys
AU5061490A (en) Bisphenethanolamines
AU613820B2 (en) Magnetic book-marker